Asarina Pharma Scientific Advisory Board gives full backing to Menstrual Migraine Phase IIA trial
Stockholm – December 18, 2018. On December 17 Asarina Pharma’s Scientific Advisory Board (SAB) gave its full backing to the company’s upcoming trial of a new prevent...



